MedTrace Logo

A Research Study to Collect Patient Reported Outcomes Using Electronic Surveys

NCT04990895 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2026-02-05

No results posted yet for this study

Summary

A single-centre, randomized, 2-arm clinical trial comparing follow-up consisting of tumour-specific Electronic Patient-Reported Outcomes (ePROs) with targeted symptom management versus standard of care follow-up during neoadjuvant/adjuvant systemic therapy

Conditions

Interventions

OTHER

Electronic Tumour-Specific Patient-Reported Outcomes (ePRO) questionnaires

A web-based portal that prompts participants to enter tumour-specific ePROs at regular intervals in between clinic visits

Sponsors & Collaborators

  • Tom Baker Cancer Centre

    collaborator OTHER

  • AHS Cancer Control Alberta

    lead OTHER

Principal Investigators

  • Nancy A Nixon, M.D. · Arthur J.E. Child Comprehensive Cancer Centre

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-30
Primary Completion
2025-09-25
Completion
2025-09-25

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04990895 on ClinicalTrials.gov